Trials / Conditions / Dasatinib
Dasatinib
3 registered clinical trials studyying Dasatinib.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Dasatinib Plus Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for Elderly Ph-positive ALL Patients NCT05523661 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 1 |
| Unknown | Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP NCT04155411 | Shenzhen Second People's Hospital | Phase 4 |
| Terminated | Dasatinib In Waldenström Macroglobulinemia NCT04115059 | Jorge J. Castillo, MD | Phase 1 |